Starpharma Holdings Limited (SPL) Stock Statistics & Valuation Metrics

Starpharma Holdings Limited has a market cap or net worth of $127.56M. The enterprise value is AU$23.80M.

Starpharma Holdings Limited has 418,224,800 shares outstanding. The number of shares has decreased by -2.65% in one year.

Starpharma Holdings Limited’s return on equity (ROE) is ― and return on invested capital (ROIC) is ―.

The current PE Ratio of Starpharma Holdings Limited is ―. Starpharma Holdings Limited’s PEG ratio is 0.00.

In the last 12 months, Starpharma Holdings Limited had revenue of 4.91M and earned -9.99M in profits. Earnings per share was -0.02.

In the last 12 months, operating cash flow was -6.76M and capital expenditures -42.00K, giving a free cash flow of -6.80M billion.

Starpharma Holdings Limited pays an annual dividend of ―, resulting in a dividend yield of ―

Starpharma Holdings Limited upcoming earnings date is Mar 3, 2026, TBA (Confirmed).

Starpharma Holdings Limited as a current ratio of ―, with Debt / Equity ratio of 10.68%

In the past 12 months, Starpharma Holdings Limited has paid -8.36M in taxes.

Starpharma Holdings Limited EV to EBITDA ratio is ―, with an EV/FCF ratio of ―.

Starpharma Holdings Limited has $15.41M in cash and marketable securities with $2.40M in debt, giving a net cash position of $13.01M billion.

Gross margin is -138.24%, with operating margin of ―, and net profit margin of ―.

The average price target for Starpharma Holdings Limited is ―, which is 11.43% higher than the current price. The consensus rating is Hold